Quick Dispatch:
Your bso glutathione inhibitor Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your bso glutathione inhibitor Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma ships.
Need Help?
Questions about bso glutathione inhibitor Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for bso glutathione inhibitor Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma in your area.
Development of a mouse model expressing a bifunctional glutathione-synthesizing enzyme to study glutathione limitation in vivo
29.01
Buthionine Sulfoximine - an overview
29.37
Frontiers
20.50
Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy
25.03
D, L-Buthionine-(S, R)-sulfoximine recapitulates the anti-obesity effects of sulfur amino acid restriction without the associated deleterious effects on bone in male mice
29.43
L-Buthionine-sulfoximine
22.02
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression: Cancer Cell
23.04
